Medy-Tox Balance Sheet Health
Financial Health criteria checks 6/6
Medy-Tox has a total shareholder equity of ₩494.8B and total debt of ₩80.8B, which brings its debt-to-equity ratio to 16.3%. Its total assets and total liabilities are ₩633.5B and ₩138.7B respectively. Medy-Tox's EBIT is ₩14.6B making its interest coverage ratio 10.2. It has cash and short-term investments of ₩36.7B.
Key information
16.3%
Debt to equity ratio
₩80.80b
Debt
| Interest coverage ratio | 10.2x |
| Cash | ₩36.67b |
| Equity | ₩494.75b |
| Total liabilities | ₩138.74b |
| Total assets | ₩633.50b |
Recent financial health updates
No updates
Recent updates
Medy-Tox Inc. (KOSDAQ:086900) Surges 37% Yet Its Low P/S Is No Reason For Excitement
Jul 19
Medy-Tox's (KOSDAQ:086900) Anemic Earnings Might Be Worse Than You Think
Mar 31Medy-Tox Inc.'s (KOSDAQ:086900) Prospects Need A Boost To Lift Shares
Feb 27Tread With Caution Around Medy-Tox Inc.'s (KOSDAQ:086900) 0.4% Dividend Yield
Apr 02A Look At Medy-Tox's (KOSDAQ:086900) Share Price Returns
Feb 09
Read This Before Buying Medy-Tox Inc. (KOSDAQ:086900) For Its Dividend
Dec 18Financial Position Analysis
Short Term Liabilities: A086900's short term assets (₩162.1B) exceed its short term liabilities (₩130.2B).
Long Term Liabilities: A086900's short term assets (₩162.1B) exceed its long term liabilities (₩8.5B).
Debt to Equity History and Analysis
Debt Level: A086900's net debt to equity ratio (8.9%) is considered satisfactory.
Reducing Debt: A086900's debt to equity ratio has reduced from 27.7% to 16.3% over the past 5 years.
Debt Coverage: A086900's debt is well covered by operating cash flow (31%).
Interest Coverage: A086900's interest payments on its debt are well covered by EBIT (10.2x coverage).